Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.920
+0.100 (5.49%)
At close: Mar 9, 2026, 4:00 PM EDT
1.950
+0.030 (1.56%)
After-hours: Mar 9, 2026, 4:04 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $289.23 million as of March 9, 2026. Its market cap has increased by 128.28% in one year.
Market Cap
289.23M
Enterprise Value
151.88M
1-Year Change
128.28%
Ranking
Category
Stock Price
$1.92
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $289.23M, a decrease of -28.44%. That is a compound annual growth rate of -2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 220.00M | 28.21% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Context Therapeutics | 286.66M |
| AC Immune | 276.05M |
| OmniAb | 273.64M |
| Enlivex | 270.61M |
| Prelude Therapeutics | 266.14M |
| Cellectis | 265.08M |
| Fennec Pharmaceuticals | 262.98M |
| Abeona Therapeutics | 262.83M |